Based on these findings, CD45, CD56, CD19, cyCD3, and smCD3 were selected from all markers evaluated, as the minimum combination of backbone markers for identification of non-hematopoietic and hematopoietic tumor cells (except in ALCL and HL infiltrated samples). The gene discussed is CD19; the disease is neoplasm.